AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

IJPR

Published November 8, 2026 · Updated November 9, 2026

Kristina Hunter and Ana Holub Discuss How to Bring Discernment to Psychedelic Healing

Read the full story at IJPR

Thursday November 19th 6:30 to 8:00 pm When is psychedelic medicine an appropriate exploration, and when is it not?

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics